Zhejiang Shengda Bio-Pharm Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Shengda Biopharmaceutical Co., Ltd. (securities code: 603079) is mainly engaged in the research and development, production, and sales of food and feed additives. Its products include vitamin products such as biotin and folic acid, as well as biological preservatives such as lactic acid streptococcin and natamycin. It strictly organizes production and operation in accordance with the GMP management system. At the same time, the company has passed international system certifications such as ISO22000, BRC, FAMI-QS, OHSAS18001, etc. The company is one of the earliest enterprises in China to engage in the production of biotin and biological preservatives. It is a high-tech enterprise with municipal academician workstations, provincial-level technology centers, and provincial-level research institutes. The company's products have strong competitiveness, and its subsidiary, New Silver Elephant, is one of the main suppliers of lactic acid streptococcin and natamycin globally. It is the main drafting unit for the industry standards for lactic acid streptococcin and the national standards for natamycin. The company has been awarded honorary titles such as "China Quality Integrity Enterprise", "Zhejiang Province Medium sized Enterprise with Growth Potential", and "Zhejiang Province Industrial Circular Economy Demonstration Enterprise". The company adheres to the core values of "customer first, people-oriented, professional and enterprising, integrity and win-win", focuses on the vitamin and natural preservatives industry, and is committed to becoming an excellent enterprise in the global food and animal nutrition field, providing customers with "safe, sustainable, and innovative" food, feed additives, and natural preservatives solutions. |
| Headquarter | Taizhou |
| Establish Date | 2/8/1999 |
| Listed Code | 603079.SH |
| Listed Date | 8/23/2017 |
| Chairman | Hong Ai. |
| CEO | Zhou Bin. |
| Website | www.sd-pharm.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
